PMC:7755033 / 91339-91565
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1722 | 34-36 | Species | denotes | WS | Tax:126910 |
1723 | 101-109 | Chemical | denotes | Losartan | |
1724 | 111-123 | Chemical | denotes | Procainamide | MESH:D011342 |
1725 | 125-135 | Chemical | denotes | Cinacalcet | MESH:D000069449 |
1726 | 137-144 | Chemical | denotes | Arbidol | MESH:C086979 |
1727 | 146-164 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
1728 | 166-176 | Chemical | denotes | Oberadilol | |
1729 | 178-188 | Chemical | denotes | Poziotinib | MESH:C557213 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T933 | 0-9 | Sentence | denotes | Figure 7. |
T934 | 11-226 | Sentence | denotes | PCA of leadlikeness of WS phytoconstituents versus FDA–approved standard reference drugs (Losartan, Procainamide, Cinacalcet, Arbidol, Hydroxychloroquine, Oberadilol, Poziotinib). (A) Scatter Plot (B) 3D Point Plot. |